IL17A and alcoholic liver diseases: As shown in Figure 4B, the results of the GO analysis were enriched mainly in the interleukin-17 signaling pathway, alcoholic liver disease, the NF-kappa B signaling pathway, and the NOD-like receptor signaling pathway.